Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Bismuth Subcitrate, Tetracycline and Metronidazole (A02bd08) as Part of a So-Call...

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Estradiol (G03ca03) as Part of a So-Called Open House Model.

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Rituximab

Conclusion of Cooperation Agreements to Arrange Memberships

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Tocilizumab

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V by Means of an Open House Model for the Active Ingredient Combination Formoterol/Glycopyrronium/Budesonide (Atc Code According to Who: R03al11)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Ganirelix (H01cc01) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredients Calcipotriol and Betamethasone (D05ax22), Excluding Ointments as Part of a So-Called Op...

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Budesonide (Atc Code According to Who: A07ea06)

Market Exploration: Intermediate Sewage Sludge Ash Storage from January 1St, 2029